Obese women in Canada are less likely to be screened for cervical cancerJune 18, 2008University of Alberta study Research in the United States has shown that obese people are less likely than their normal-weight peers to undergo screening for breast, colon and cervical cancer. Raj Padwal, Rebecca Mitchell and Scott Klarenbach, from the University of Alberta's Faculty of Medicine & Dentistry, have undertaken a study to see if this trend is also true in Canada. "As obesity is associated with higher rates of some types of cancer, it's important to determine if the presence of obesity influences the use of screening tests," said Padwal.
In 2007 almost 38,000 women participated in a national survey. The women, aged 20-69, were asked questions including: * their Body Mass Index (to determine the level of obesity) * whether they have a regular doctor * did they get breast, colon and cervical cancer screening tests regularly; if so, how often; if not, what are the reasons? Padwal said for the most part, the results were encouraging. For breast and colon cancer screening the data showed no difference between overweight/obese women and normal-weight women. But for cervical cancer screening the results were different. While 82 per cent of women said they had a pap smear in the past three years, testing decreased as BMI levels increased. "Obese women are 30 to 40 per cent less likely-depending on the degree of obesity-to have recommended cervical cancer screening performed." Padwal says the results also showed obese women are two times more likely than normal-weight women to state that fear-including fear of pain, embarrassment or of finding something wrong-was the reason they did not have a pap smear. "I am reassured that for mammograms and colorectal cancer screening, the presence of obesity doesn't impact their use, which is different from reports in other countries. However, the gap with pap smears is concerning," he said. Padwal believes this is an issue that needs to be addressed through increased awareness and vigilance on the part of patients and health care providers. He says more studies are needed to determine if other barriers exist and, if so, what are the best methods of removing those barriers. University of Alberta | |||||||||||||||||||||
|
Related Cervical Cancer Current Events and Cervical Cancer News Articles Social class dictates cancer risk Cervical and lung cancer are more common in poor people while rates of breast cancer and melanoma are higher in the wealthy. Model highlights benefits and risks of cervical cancer screening methods In an analysis based on a computer model, it appears that comparing the benefits and risks of different cervical cancer prevention approaches may help women and their physicians choose appropriate screening strategies. New HPV test for developing countries shows high accuracy in predicting cervical disease: Study A new HPV test developed by QIAGEN specifically for use in regions of the world with scarce resources is "substantially" more accurate in identifying women with cervical disease than the current methods (Pap testing and visual inspection) in these countries. As head and neck cancer risks evolve, more treatment options emerge Advances in understanding head and neck cancer over the last decade have led to more treatment options and improved quality of life for patients, according to a review published this week in the New England Journal of Medicine. Cervical cancer prevention should focus on vaccinating adolescent girls The cost-effectiveness of vaccination in the United States against human papillomavirus (HPV), a sexually-transmitted virus that causes cervical cancer, will be optimized by achieving universal vaccine coverage in young adolescent girls, by targeting initial "catch-up" efforts to vaccinate women younger than 21 years of age, and by revising current screening policies. Breaking the 'mucus barrier' with a new drug delivery system Chemical engineers from Johns Hopkins University have broken the "mucus barrier," engineering the first drug-delivery particles capable of passing through human mucus - regarded by many as nearly impenetrable - and carrying medication that could treat a range of diseases. Those conditions include lung cancer, cervical cancer and cystic fibrosis, the research noted in a presentation scheduled for the 236th National Meeting of the American Chemical Society. Novel structure proteins could play a role in apoptosis Isoforms from Novel Structure Proteins (NSP), a new family of genes discovered by researchers in the Sbarro Institute for Cancer Research and Molecular Medicine in Temple University's College of Science and Technology, could be involved in apoptosis or programmed cell death. New study shows potential to treat or prevent viral cancers A new study, presented at the SNM 55th Annual Meeting, shows that radioimmunotherapy (RIT) targeting viral antigens offers a novel option to treat-or even prevent-many viral cancers by targeting cancer cells expressing viral antigens or infected cells before they convert into malignancy. Avoiding Spleen Removal for Cooley's Anemia Sufferers Researchers from Weill Cornell Medical College may have discovered the precise role of a gene in one of the world's most common blood disorders, beta-thalassemia, commonly known as Cooley's anemia. Estrogen Helps Drive Distinct, Aggressive Form of Prostate Cancer Using a breakthrough technology, researchers led by a Weill Cornell Medical College scientist have pinpointed the hormone estrogen as a key player in about half of all prostate cancers. More Cervical Cancer Current Events and Cervical Cancer News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||